Table 5.
Changes in biometric outcomes, APFHL study 2020.
| Baseline | Post-Intervention | Within Group Changes 1 | Net Changes 1 in Intervention Group | |||||
|---|---|---|---|---|---|---|---|---|
| n | Estimated Marginal Means (95% CI 2) |
n | Estimated Marginal Means (95% CI) |
Marginal Differences (95% CI) |
p-Value | Delta (95% CI) |
p-Value | |
| HbA1c | ||||||||
| APFHL + Food Rx group | 33 | 9.60 (8.87, 10.33) |
28 | 8.63 (7.84, 9.43) |
−0.96 (−1.82, −0.10) |
0.028 * | −0.48 (−1.55, 0.59) |
0.378 |
| Food Rx-only group | 75 | 9.50 (9.01, 9.99) |
50 | 9.02 (8.43, 9.61) |
−0.48 (−1.12, 0.15) |
0.137 | ||
| Systolic Blood Pressure | ||||||||
| APFHL+Food Rx group | 29 | 132.57 (125.07, 140.06) |
26 | 133.03 (125.18, 141.87) |
0.46 (−7.56, 8.48) |
0.217 | 3.90 (−5.82, 13.63) |
0.431 |
| Food Rx-only group | 71 | 132.85 (127.99, 137.71) |
55 | 129.40 (123.96, 134.84) |
−3.44 (−8.92, 2.04) |
0.798 | ||
| Diastolic Blood Pressure | ||||||||
| APFHL+Food Rx group | 29 | 73.48 (69.45, 77.50) |
26 | 70.46 (66.23, 74.68) |
−3.02 (−7.55, 1.50) |
0.190 | −2.53 (−8.01, 2.96) |
0.366 |
| Food Rx-only group | 71 | 75.23 (72.63, 77.84) |
55 | 74.74 (71.80, 77.67) |
−0.50 (−3.58, 2.59) |
0.753 | ||
| BMI 3 | ||||||||
| APFHL + Food Rx group | 27 | 34.99 (32.20, 37.78) |
22 | 34.77 (31.96, 37.58) |
−0.22 (−1.18, 0.74) |
0.649 | −0.23 (−1.37, 0.91) |
0.693 |
| Food Rx-only group | 69 | 33.55 (31.70, 35.40) |
51 | 33.56 (31.68, 35.44) |
0.007 (−0.61, 0.63) |
0.982 | ||
1 Adjusted estimations were obtained using multilevel mixed-effects linear model adjusted for age, gender, ethnicity, and food insecurity status. 2 CI stands for confidence interval. 3 BMI stands for body mass index. * significant at p < 0.05.